Screening for heterozygous mutations in the gene homozygously mutated in the cancer-prone, radiosensitivity disorder, ataxia-telangiectasia (ATM: AT mutated) in radiosensitive patients has been vigorously pursued during the past few years. This evidence concerns the gene ATM and cancer.